Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-03-01 McKenzie Paul EVP Pharmaceutical Oper & Tech Other disposition · Restricted Stock Unit −363 1,692
2017-03-01 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Sale −973 $290.07 $282K 9,040.86
2017-02-28 Clancy Paul J Executive VP and CFO Exercise or conversion +663 27,533
2017-02-28 Clancy Paul J Executive VP and CFO Shares withheld for taxes −312 $284.75 $89K 27,221
2017-02-28 Clancy Paul J Executive VP and CFO Exercise or conversion +2,092 29,313
2017-02-28 Clancy Paul J Executive VP and CFO Shares withheld for taxes −847 $287.63 $244K 28,466
2017-02-28 Clancy Paul J Executive VP and CFO Exercise or conversion +1,152 29,618
2017-02-28 Clancy Paul J Executive VP and CFO Shares withheld for taxes −543 $274.76 $149K 29,075
2017-02-28 Clancy Paul J Executive VP and CFO Exercise or conversion +2,873 31,948
2017-02-28 Clancy Paul J Executive VP and CFO Shares withheld for taxes −1,352 $274.76 $371K 30,596
2017-02-28 Clancy Paul J Executive VP and CFO Other disposition · Restricted Stock Unit −1,352 1,152
2017-02-28 Clancy Paul J Executive VP and CFO Other disposition · Restricted Stock Unit −1,678 9,638
2017-02-28 Clancy Paul J Executive VP and CFO Other disposition · Restricted Stock Unit −1,105 2,437
2017-02-28 Clancy Paul J Executive VP and CFO Exercise or conversion · Restricted Stock Unit −663 1,774
2017-02-28 Clancy Paul J Executive VP and CFO Exercise or conversion · Restricted Stock Unit −2,092 7,546
2017-02-28 Clancy Paul J Executive VP and CFO Exercise or conversion · Restricted Stock Unit −1,152 0
2017-02-28 Clancy Paul J Executive VP and CFO Exercise or conversion · Restricted Stock Unit −2,873 0
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Exercise or conversion +1,375 9,584.86
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Shares withheld for taxes −647 $287.63 $186K 8,937.86
2017-02-28 Sandrock Alfred EVP CMO Neuro & Neurodegenerat Exercise or conversion +398 9,335.86

Page 63 of 73 · 1,456 trades